Lumira Dx LTD LMDX
We take great care to ensure that the data presented and summarized in this overview for LumiraDx Ltd is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding LMDX
View all-
Bill & Melinda Gates Foundation Seattle, WA14.3MShares$142,8570.17% of portfolio
-
Bdo Wealth Advisors, LLC Jacksonville, FL186KShares$1,8620.01% of portfolio
-
Colony Group LLC Boston, MA133KShares$1,3260.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ45.7KShares$4570.0% of portfolio
-
Xtx Topco LTD London, X030.4KShares$3030.0% of portfolio
-
Hyman Charles D30KShares$3000.0% of portfolio
-
Cwm, LLC24.3KShares$2430.0% of portfolio
Latest Institutional Activity in LMDX
Top Purchases
Top Sells
About LMDX
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions from the lab to point of need. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company was founded in 2014 and is headquartered in London, the United Kingdom.
Insider Transactions at LMDX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|